About the Company
- GST Registration Date
- 01-05-2021
- Legal Status of Firm
- Proprietorship
- Nature of Business
- Trader - Retailer
- Annual Turnover
- 40 L - 1.5 Cr
- IndiaMART Member Since
- Sept 2025
- GST
- 27CUQPG4476C1ZE
- Import Export Code (IEC)
- CUQPG*****
- Exports to
- United States Of America | United Kingdom | Australia | Philippines | France
Established in 2021, Decent Medipharm is a trusted Retailer, Trader and Exporter of a wide range of Bevacizumab Injection, Trastuzumab Injections, Anti Cancer Tablet, Tirzepatide Insulin Pen, Anti Cancer Injection, Rituximab Injections and more. We are dedicated to meeting customer expectations by delivering excellent quality products, while adhering to ethical business practices and complete transparency in all our transactions, enabling us to build and maintain strong, long-term relationships with our clients.
For our accomplishment story, we are grateful to our Mr. Nitesh Mohan Gehani [CEO], whose continual backing and direction have been useful to us for attaining exponential development in the current market.